Financials
- Financial year
- 2025
- Turnover
- €583.2m
- Profit
- €22.1m
- Solvency
- 18.5%
Turnover▼ 3.1%
Net result
20182025
Evonik Antwerpen
ActiveSummary
Evonik Antwerpen has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €61.5m and a net result of €22.1m. Equity is shrinking by about 13% per year across the filed financial years. Its solvency ranks better than 15% of 317 sector peers (NACE 20, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Activity
Manufacture of chemicals and chemical products
NACE 20200Manufacture of chemicals and chemical products NACE 20130Manufacture of chemicals and chemical products NACE 20140
5th largest employer in the province of Antwerp, Chemicals sector3 sites
Size
€583.2mturnover 2025
- Staff
- 904.5 FTE
- Equity
- €61.5m
- Profit
- €22.1m
Structure
- Parent
- Evonik Industries AG
- Board
- 4 members
- Holdings
- 1
- Ivan PelgrimsChair
Auditor: KPMG Bedrijfsrevisoren BV/SRL2025 accounts 74 days early
Why 82raises riskLiquidity: current ratio 0.68, cash €4,985Equity €61.5m (18.5% of total assets)lowers riskSize: turnover €583.2m, 904.5 FTE, total assets €331.9mFounded in 1968Show the evidence
Checked score
Score 2025
82
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 41% of its sector peers (NACE 20, large)
Financial strength · tick = 2024
Weak
Solvency
44+5
equity 18.5% of total assets
Liquidity
8+2
short-term debt 77.9% · cash 0.0%
Profitability
71-3
return on assets 6.7%
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.6%
12-2024: 0.6%● unchanged vs 11-2024
01-2025: 0.6%● unchanged vs 12-2024
02-2025: 0.5%▼ -0.1 percentage points vs 01-2025
03-2025: 0.6%▲ +0.1 percentage points vs 02-2025
04-2025: 0.6%● unchanged vs 03-2025
05-2025: 0.6%● unchanged vs 04-2025
06-2025: 0.6%● unchanged vs 05-2025highest value
07-2025: 0.6%● unchanged vs 06-2025highest value
08-2025: 0.6%● unchanged vs 07-2025highest value
09-2025: 0.6%● unchanged vs 08-2025highest value
10-2025: 0.6%● unchanged vs 09-2025highest value
11-2025: 0.6%● unchanged vs 10-2025highest value
12-2025: 0.6%● unchanged vs 11-2025highest value
01-2026: 0.6%● unchanged vs 12-2025highest value
02-2026: 0.6%● unchanged vs 01-2026
03-2026: 0.6%● unchanged vs 02-2026
04-2026: 0.6%● unchanged vs 03-2026
05-2026: 0.6%● unchanged vs 04-2026
06-2026: 0.4%▼ -0.2 percentage points vs 05-2026lowest value
07-2026: 0.4%● unchanged vs 06-2026lowest value
08-2026: 0.4%● unchanged vs 07-2026lowest value
09-2026: 0.4%● unchanged vs 08-2026lowest value
10-2026: 0.4%● unchanged vs 09-2026lowest value
Credit of up to €5,000,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.68, compared with 0.64 in 2024, below 1; short-term debt: 77.9% and cash: 0% of total assets), and 81.5% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 20, large): better than 13% on solvency, 8% on liquidity, 67% on profitability and 75% on growth.
The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Seven signals.
lowers riskraises riskneutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 317 sector peers (2025).
NBB · sector comparisonPosition among 317 sector peers
Solvency
better than 15%
← weakest
strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €61.5m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-05-2026, 74 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
74 days early
2024
69 days early
2023
75 days early
2022
77 days early
2021
60 days early
2020
72 days early
2019
37 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 66 days before the deadline; the sector median (NACE 20) for financial year 2024 is 22 days before the deadline, and 27% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
- Reappointments: Ivan PELGRIMS, Guy HEYNINCK and…Gazette deed
- Annual accounts filedfinancial year 2025 · full…
- Equity above €50mequity €61.5m ▲56.2%
Key points
- Positive: Among the best 5% on net resultsector median €461,868 · 318 companies €22.1m View
- Positive: Equity rose in 2025from €39.4m to €61.5m ▲ 56.2% View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Positive: 8 profitable years in a rowprofit 2025: €22.1m 8 years View
- Controlled by Evonik Industries AGthe company in turn controls 1 companies parent View
- Flemish supportawarded from 2022 to 2025 €5.2m View
- Active since 1968founded 03-10-1968 58 years View
By topic
Board & ownership
- Board
- 4 members
- Parent
- Evonik Industries AG
- Auditor
- KPMG Bedrijfsrevisoren BV/SRL
- Ivan PelgrimsChair
- Bart Van RoleDirector
- Maurizio FinottoDirector
- Guy HeyninckDirector
Network & group
- Subsidiaries
- 1
- Connected companies
- 5
- Mergers and asset contributions
- 2
1 subsidiary
Timeline
- Events
- 86
- Since
- 1979
- Next accounts
- by 31-07-2027
- 30-10-2025Permanent representatives: Christophe Van Parys and Tim…
- 23-05-2025Annual accounts filed
- 11-10-2024Resignation: Bart Van Roie (director)
Company details
- Sites
- 3
- Legal form
- Public limited company
- Activity
- Manufacture of chemicals and chemical productsNACE 20200
- Founded
- 03-10-1968
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 3
- Purpose
- “De fabricage en de verkoop van scheikundige,scheikundig-technische en metallurgie…” (deed in Dutch)
Key facts about Evonik Antwerpen
- What is the company number of Evonik Antwerpen?
- 0406.183.144. In Belgium the VAT number is the company number with BE in front: BE 0406.183.144.
- Where is Evonik Antwerpen based?
- The registered office is at Tijsmanstunnel-West Z/N, 2040 Antwerpen.Company details
- What does Evonik Antwerpen do?
- According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20200).
- What is the legal form of Evonik Antwerpen?
- Public limited company (NV).
- When was Evonik Antwerpen founded?
- On 03-10-1968.
- Is Evonik Antwerpen still active?
- Yes, Evonik Antwerpen is an active enterprise in the KBO register.
- How many employees does Evonik Antwerpen have?
- On average 904.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of Evonik Antwerpen?
- €583.2m in financial year 2025, according to the filed annual accounts.
- Is Evonik Antwerpen profitable?
- In financial year 2025, Evonik Antwerpen made a profit of €22.1m.
- Where can I find the annual accounts of Evonik Antwerpen?
- Evonik Antwerpen filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Evonik Antwerpen due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Evonik Antwerpen
Subsidiaries and holdings
- EVONIK PORPHYRIO100%
Comparable companies
- DECOSPANMenen
- West Fraser EuropeGenk
- ISK BIOSCIENCES EUROPEMachelen (Brab.)
- Bayer AgricultureAntwerpen
- ARYSTA LIFESCIENCE BENELUXSeraing
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.